Dr. Amirali Popatia, M.D.
What this data tells you about Dr. Popatia
Dr. Amirali Popatia is an optician in Richmond, TX, with 19 years in practice. Based on federal Medicare data, Dr. Popatia performed 27,306 Medicare services across 873 unique beneficiaries.
Between the years covered by Open Payments, Dr. Popatia received a total of $18,397 from 71 pharmaceutical and/or device companies across 829 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Popatia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 9,600 | $19 | $50 |
| Dexamethasone injection (steroid) | 4,120 | $0 | $2 |
| Epoetin alfa injection (Retacrit) for anemia | 3,960 | $6 | $40 |
| Infusion, normal saline solution, 250 cc | 1,064 | $1 | $15 |
| Injection, leucovorin calcium, per 50 mg | 1,025 | $3 | $10 |
| Injection, granisetron hydrochloride, 100 mcg | 930 | $0 | $5 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 785 | $22 | $75 |
| Injection, fluorouracil, 500 mg | 773 | $2 | $25 |
| Injection of additional new drug or substance into vein | 543 | $12 | $75 |
| Injection, magnesium sulfate, per 500 mg | 500 | $1 | $2 |
| 5% dextrose/normal saline (500 ml = 1 unit) | 462 | $1 | $15 |
| Administration of chemotherapy into vein, 1 hour or less | 458 | $97 | $325 |
| Injection, diphenhydramine hcl, up to 50 mg | 396 | $1 | $2 |
| Infusion into a vein for hydration, each additional hour | 353 | $10 | $50 |
| Office visit, established patient (30-39 min) | 348 | $91 | $175 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 318 | $340 | $1,200 |
| Administration of additional new drug or substance into vein, 1 hour or less | 311 | $49 | $200 |
| Administration of chemotherapy into vein, each additional hour | 298 | $21 | $150 |
| Office visit, established patient, complex (40-54 min) | 268 | $133 | $200 |
| Drug injection, under skin or into muscle | 209 | $11 | $50 |
| Office visit, established patient (20-29 min) | 209 | $66 | $125 |
| Administration of additional new drug or substance into vein using push technique | 152 | $42 | $125 |
| Injection of drug or substance into vein | 81 | $28 | $100 |
| Infusion into a vein for hydration, 31-60 minutes | 55 | $25 | $100 |
| Office visit, established patient (10-19 min) | 34 | $42 | $100 |
| New patient office visit, complex (60-74 min) | 32 | $168 | $350 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 22 | $48 | $120 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for optician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Popatia is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (low-engagement, top 10%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Popatia experienced with denosumab injection (prolia/xgeva)?
Does Dr. Popatia receive payments from pharmaceutical companies?
How do Dr. Popatia's costs compare to other opticians in Richmond?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology